Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 387 | 1,865 | 1,052 | 1,858 | 4,349 |
| Receivables | 984 | 318 | 638 | 848 | 869 |
| TOTAL | $1,584 | $2,359 | $1,899 | $2,982 | $5,576 |
| Non-Current Assets | |||||
| PPE Net | 30 | 11 | 10 | 11 | 13 |
| TOTAL | $30 | $11 | $10 | $11 | $13 |
| Total Assets | $1,615 | $2,370 | $1,908 | $2,993 | $5,588 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 161 | 86 | 76 | 77 | 77 |
| Accounts payable and accrued liabilities | 2,378 | 2,136 | 1,820 | 1,094 | 2,639 |
| TOTAL | $2,579 | $2,252 | $1,921 | $1,261 | $2,808 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,557 | 5,713 | 3,936 | 4,071 | 4,022 |
| Deferred Revenues | N/A | N/A | N/A | 90 | 92 |
| TOTAL | $5,557 | $5,713 | $3,936 | $4,071 | $4,022 |
| Total Liabilities | $8,135 | $7,966 | $5,857 | $5,332 | $6,830 |
| Shareholders' Equity | |||||
| Common Shares | 31,480 | 32,018 | 31,205 | 32,428 | 33,143 |
| Retained earnings | -49,731 | -49,409 | -46,193 | -45,997 | -45,728 |
| Other shareholders' equity | 6,827 | 6,944 | 6,586 | 6,755 | 6,903 |
| TOTAL | $-6,521 | $-5,596 | $-3,949 | $-2,339 | $-1,241 |
| Total Liabilities And Equity | $1,615 | $2,370 | $1,908 | $2,993 | $5,588 |